Indeed, a recent study involving conditional mouse models has shown that BRAFV600E cooperates with the loss of PTEN in the induction of metastatic melanomas [221], which underscores the idea that BRAFV600E requires increased levels of PI3K activity to drive malignant melanomas. The gene discussed is PIK3CA; the disease is melanoma.